Literature DB >> 22169840

Oral leiomyoma extending in retromolar region.

A Goel1, H Goel.   

Abstract

Leiomyoma is a benign smooth muscle tumor that rarely affects children and occurs most frequently in the uterine myometrium and gastrointestinal tract. Its occurrence in the oral cavity is considered rare probably because of the scarcity of smooth muscle tissue in the oral cavity. The most common intraoral sites for leiomyoma are lips, palate and tongue. The purpose of this case report is to present the clinical features, diagnosis and treatment of a rare case of oral leiomyoma in a 13-year-old girl with a 4-month history of a swelling in her left mandibular area extending from first molar to retromolar region.

Entities:  

Mesh:

Year:  2011        PMID: 22169840     DOI: 10.4103/0970-4388.90744

Source DB:  PubMed          Journal:  J Indian Soc Pedod Prev Dent        ISSN: 0970-4388


  4 in total

1.  Pediatric leiomyoma of the oral cavity: A rare entity.

Authors:  Srujan Kumar Peruka; Uday Kiran Uppada; Gireesha Reddy Dawalgari
Journal:  J Oral Maxillofac Pathol       Date:  2021-03-19

2.  Codelivery of VEGF siRNA and gemcitabine monophosphate in a single nanoparticle formulation for effective treatment of NSCLC.

Authors:  Yuan Zhang; Nicole Mj Schwerbrock; Arlin B Rogers; William Y Kim; Leaf Huang
Journal:  Mol Ther       Date:  2013-06-18       Impact factor: 11.454

3.  Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment.

Authors:  Jing Zhang; Peng Zhang; Qian Zou; Xiang Li; Jianjiang Fu; Ying Luo; Xinli Liang; Yi Jin
Journal:  Molecules       Date:  2018-11-07       Impact factor: 4.411

4.  Construction of novel multifunctional luminescent nanoparticles based on DNA bridging and their inhibitory effect on tumor growth.

Authors:  Qiaobei Pan; Jing Zhang; Xiang Li; Qian Zou; Peng Zhang; Ying Luo; Yi Jin
Journal:  RSC Adv       Date:  2019-05-14       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.